tiprankstipranks
Trending News
More News >
Utah Medical Products (UTMD)
:UTMD
US Market
Advertisement

Utah Medical Products (UTMD) Ratios

Compare
121 Followers

Utah Medical Products Ratios

UTMD's free cash flow for Q1 2025 was $0.57. For the 2025 fiscal year, UTMD's free cash flow was decreased by $ and operating cash flow was $0.40. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
41.87 22.56 15.63 20.32 16.42
Quick Ratio
38.22 20.53 14.10 18.49 14.78
Cash Ratio
0.00 19.72 13.05 16.94 13.61
Solvency Ratio
4.30 3.22 2.45 2.62 2.02
Operating Cash Flow Ratio
6.22 4.73 3.68 5.89 5.31
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 91.11M$ 99.12M$ 80.30M$ 64.73M$ 53.34M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.03 1.06 1.08 1.08 1.09
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.08 0.08 0.09 0.09 0.09
Net Debt to EBITDA
0.02 -3.74 -2.78 -2.32 -2.45
Profitability Margins
Gross Profit Margin
55.94%59.81%61.58%63.03%60.57%
EBIT Margin
36.81%36.71%37.85%38.49%32.50%
EBITDA Margin
40.69%49.28%51.40%53.34%49.59%
Operating Profit Margin
32.51%33.40%24.31%38.49%15.41%
Pretax Profit Margin
39.89%40.00%39.52%38.86%32.81%
Net Profit Margin
32.33%33.12%31.51%30.15%25.60%
Continuous Operations Profit Margin
32.33%33.12%31.51%30.15%25.60%
Net Income Per EBT
81.06%82.81%79.74%77.58%78.02%
EBT Per EBIT
122.71%119.74%162.57%100.96%212.96%
Return on Assets (ROA)
10.39%12.28%13.30%12.80%9.66%
Return on Equity (ROE)
10.53%12.96%14.42%13.80%10.50%
Return on Capital Employed (ROCE)
10.65%12.83%10.76%16.86%6.02%
Return on Invested Capital (ROIC)
8.63%10.63%8.58%13.08%4.70%
Return on Tangible Assets
12.00%14.24%16.38%17.57%14.67%
Earnings Yield
6.41%5.43%4.51%4.05%3.50%
Efficiency Ratios
Receivables Turnover
10.69 15.05 9.44 9.56 10.28
Payables Turnover
23.21 26.25 16.49 23.83 21.10
Inventory Turnover
2.08 2.11 2.28 2.75 2.67
Fixed Asset Turnover
3.79 4.76 4.92 4.46 3.72
Asset Turnover
0.32 0.37 0.42 0.42 0.38
Working Capital Turnover Ratio
0.42 0.54 0.68 0.77 0.77
Cash Conversion Cycle
194.08 183.61 176.70 155.61 154.78
Days of Sales Outstanding
34.14 24.26 38.66 38.19 35.52
Days of Inventory Outstanding
175.66 173.26 160.17 132.74 136.56
Days of Payables Outstanding
15.72 13.90 22.13 15.31 17.30
Operating Cycle
209.81 197.52 198.84 170.93 172.08
Cash Flow Ratios
Operating Cash Flow Per Share
4.13 6.13 5.81 5.81 5.50
Free Cash Flow Per Share
4.08 5.95 5.59 5.66 5.27
CapEx Per Share
0.05 0.18 0.22 0.15 0.24
Free Cash Flow to Operating Cash Flow
0.99 0.97 0.96 0.97 0.96
Dividend Paid and CapEx Coverage Ratio
3.22 4.53 5.31 1.76 4.05
Capital Expenditure Coverage Ratio
81.98 34.87 25.85 38.41 23.42
Operating Cash Flow Coverage Ratio
54.76 75.53 62.01 64.06 60.11
Operating Cash Flow to Sales Ratio
0.36 0.44 0.40 0.43 0.48
Free Cash Flow Yield
7.38%7.07%5.56%5.66%6.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.61 18.41 22.20 24.66 28.56
Price-to-Sales (P/S) Ratio
4.83 6.10 6.99 7.43 7.31
Price-to-Book (P/B) Ratio
1.67 2.39 3.20 3.40 3.00
Price-to-Free Cash Flow (P/FCF) Ratio
13.55 14.15 17.99 17.66 16.00
Price-to-Operating Cash Flow Ratio
13.98 13.75 17.29 17.20 15.31
Price-to-Earnings Growth (PEG) Ratio
-0.62 20.85 1.87 0.66 -1.12
Price-to-Fair Value
1.67 2.39 3.20 3.40 3.00
Enterprise Value Multiple
11.89 8.63 10.83 11.62 12.29
Enterprise Value
187.91M 213.72M 290.92M 304.06M 257.11M
EV to EBITDA
11.89 8.63 10.83 11.62 12.29
EV to Sales
4.84 4.26 5.56 6.20 6.10
EV to Free Cash Flow
13.57 9.88 14.31 14.72 13.34
EV to Operating Cash Flow
13.40 9.59 13.76 14.34 12.77
Tangible Book Value Per Share
34.65 30.16 24.89 20.76 17.68
Shareholders’ Equity Per Share
34.65 35.28 31.41 29.38 28.11
Tax and Other Ratios
Effective Tax Rate
0.19 0.17 0.20 0.22 0.22
Revenue Per Share
11.45 13.81 14.37 13.45 11.53
Net Income Per Share
3.70 4.57 4.53 4.05 2.95
Tax Burden
0.81 0.83 0.80 0.78 0.78
Interest Burden
1.08 1.09 1.04 1.01 1.01
Research & Development to Revenue
0.02 0.01 <0.01 0.01 0.01
SG&A to Revenue
0.04 0.22 0.20 0.21 0.23
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.08 1.34 1.28 1.43 1.86
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis